High refill-adherence to adalimumab is associated with low disease activity in patients with inflammatory bowel disease
San, Esma H., Egberts, Angelique, van Dijck - van Boetzelaer, Caroline W. Th, West, Rachel L., Vasbinder, Erwin C.
Published in European journal of clinical pharmacology (01.07.2024)
Published in European journal of clinical pharmacology (01.07.2024)
Get full text
Journal Article